Skip to content

Intra-Abdominal Instillation Of Fresh Frozen Plasma Versus Corticosteroids In Prevention Of Recurrent Attacks Of Adhesive Intestinal Obstruction: A 2 Years' Experience Clinical Study

Intra-Abdominal Instillation Of Fresh Frozen Plasma Versus Corticosteroids In Prevention Of Recurrent Attacks Of Adhesive Intestinal Obstruction: A 2 Years' Experience Clinical Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06859307
Enrollment
176
Registered
2025-03-05
Start date
2025-03-01
Completion date
2027-03-01
Last updated
2025-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive Peritoneal Band

Keywords

adhesions, corticosteroids, fresh frozen plasma

Brief summary

Adhesive Intestinal obstruction is an inevitable complication of abdominal surgery with significant morbidity associated with poor quality of life and predispose to repeated hospitalization. Most of them (73% - 90%) can be managed conservatively.Despite advances in surgery, 15to 30% require surgical intervention primarily or due to failure of conservative management. Because of the nature of the disease recurrence has been estimated to be 30%.Many attempts to prevent formation of postoperative adhesions have been tried. In this trial, we will study the effect of corticosteroids and FFP in prevention of adhesive small bowel obstruction recurrence for follow up of 2 years duration.

Interventions

PROCEDUREintra-abdominal instillation of corticosteroids

after adhesiolysis, peritoneal lavage with diluted corticosteroids will be instillated intra-abdominally

PROCEDUREintra-abdominal instillation of fresh frozen plasma

after adhesiolysis, peritoneal lavage with diluted FFP will be instillated intra-abdominally

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with attacks of adhesive intestinal obstruction

Exclusion criteria

* Associated abdominal malignancy, patients with adhesive IO who respond to conservative treatment.

Design outcomes

Primary

MeasureTime frameDescription
intestinal obstructionfrom 1 day to 2 years post operativeintestinal obstruction is detected if the patient had constipation and vomiting with ultrasound showing dilated bowel and to and fro movement and the plain erect shows multiple air fluid levels
bowel injuryfrom 1 day to 2 years post operativebowel injury will be detected if intestinal contents present in the drain or wound
wound infectionfrom 1 day to 2 weeks post-operativewound infection is detected if there is pus in the drain or wound

Secondary

MeasureTime frameDescription
agefrom 2 to 3 days before surgeryage will be recorded in years
sexfrom 2 to 3 days before surgeryThe sex of the patient will be recorded (male or female)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026